ELI LILLY & Co — Director's Dealing 2013

Nov 21, 2013

SEC Form 3/A — Form 3/A

Issuer: Receptos, Inc. (RCPT)
CIK: 0001463729
Period of Report: 2013-05-08

Reporting Person: LILLY ELI & CO (10% Owner)
Reporting Person: Lilly Ventures Fund I LLC (10% Owner)
Reporting Person: Torres S. Edward (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2081210	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$5.25		Common Stock (1152039.0)		Indirect
Series B Preferred Stock	$7.73		Common Stock (672029.0)		Indirect

Footnotes

F1: These shares are owned directly by Lilly Ventures Fund I LLC (the "Fund"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres, is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein. The attached Exhibit 99.1 lists details for each 10% and beneficial owner.

F2: The Series A Preferred Stock and the Series B Preferred Stock have no expiration date and are convertible at any time at the option of the holder and will convert upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of Common Stock for every 7.5 shares of Series A Preferred Stock and Series B Preferred Stock, for no additonal consideration.